Neuronetics Operating Cycle from 2010 to 2026

STIM Stock  USD 1.56  0.14  9.86%   
Neuronetics Operating Cycle yearly trend continues to be very stable with very little volatility. Operating Cycle is likely to drop to 144.66. During the period from 2010 to 2026, Neuronetics Operating Cycle quarterly data regression pattern had sample variance of  2,867 and median of  131.63. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
173.84
Current Value
144.66
Quarterly Volatility
53.54520605
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Neuronetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Neuronetics' main balance sheet or income statement drivers, such as Interest Income of 3.3 M, Depreciation And Amortization of 1.3 M or Interest Expense of 4.4 M, as well as many indicators such as Price To Sales Ratio of 0.58, Dividend Yield of 0.0 or PTB Ratio of 1.89. Neuronetics financial statements analysis is a perfect complement when working with Neuronetics Valuation or Volatility modules.
  
Build AI portfolio with Neuronetics Stock
Check out the analysis of Neuronetics Correlation against competitors.
To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.
Evaluating Neuronetics's Operating Cycle across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Neuronetics's fundamental strength.

Latest Neuronetics' Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Neuronetics over the last few years. It is Neuronetics' Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Neuronetics' overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Neuronetics Operating Cycle Regression Statistics

Arithmetic Mean160.92
Geometric Mean153.94
Coefficient Of Variation33.27
Mean Deviation42.09
Median131.63
Standard Deviation53.55
Sample Variance2,867
Range183
R-Value0.55
Mean Square Error2,143
R-Squared0.30
Significance0.02
Slope5.80
Total Sum of Squares45,873

Neuronetics Operating Cycle History

2026 144.66
2025 173.84
2024 193.16
2023 241.64
2022 287.15
2021 256.91
2020 170.63

About Neuronetics Financial Statements

Neuronetics investors utilize fundamental indicators, such as Operating Cycle, to predict how Neuronetics Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Operating Cycle 173.84  144.66 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Neuronetics is a strong investment it is important to analyze Neuronetics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neuronetics' future performance. For an informed investment choice regarding Neuronetics Stock, refer to the following important reports:
Check out the analysis of Neuronetics Correlation against competitors.
To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Will Health Care Equipment & Supplies sector continue expanding? Could Neuronetics diversify its offerings? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Neuronetics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.83)
Revenue Per Share
2.238
Quarterly Revenue Growth
1.013
Return On Assets
(0.21)
Return On Equity
(2.19)
Neuronetics's market price often diverges from its book value, the accounting figure shown on Neuronetics's balance sheet. Smart investors calculate Neuronetics' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Neuronetics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.